NCT06667050 2024-10-31CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric CancerWest China HospitalPhase 2 Active not recruiting58 enrolled